Acurx Pharmaceuticals (ACXP) said Friday in a regulatory filing some selling shareholders may sell up to about 2.6 million shares.
The number of shares comprises up to about 2.46 million shares issuable upon exercise of Series E warrants acquired by some of the shareholders under a purchase agreement with an exercise price of $0.90 per share and up to 147,783 shares issuable upon exercise of placement agent warrants, the company said.
The selling shareholders will get all of the proceeds from any sales of the shares, Acurx said.
Acurx shares rose 3.3% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.